Risk-adapted simultaneous integrated boost-proton beam therapy (SIB-PBT) for advanced hepatocellular carcinoma with tumour vascular thrombosis.
CONCLUSIONS: SIB-PBT is feasible and promising for HCC patients with TVT.
PMID: 28034460 [PubMed - as supplied by publisher]
Source: Radiotherapy and Oncology : journal of the European Society for Therapeutic Radiology and Oncology - Category: Radiology Authors: Kim DY, Park JW, Kim TH, Kim BH, Moon SH, Kim SS, Woo SM, Koh YH, Lee WJ, Kim CM Tags: Radiother Oncol Source Type: research
More News: Cancer & Oncology | Carcinoma | Children | Gastroenterology | Hepatocellular Carcinoma | Liver Cancer | Radiology | Thrombosis | Toxicology